• Created a factbase covering the NASH therapeutic competitor and diagnostic landscape for a top 15 pharma company to update their biomarker strategy before a strategy planning meeting• Prioritized biomarker testing opportunities by reviewing the diagnostic and treatment landscape for solid tumor oncology for a top 3 diagnostics company• Identified market opportunities for an at-home oncology diagnostic to support a startup diagnostic’s upcoming board meeting and next fundraising round

• Managed project teams, synthesized key project findings, and delivered summarized findings and actionable recommendations for clients to inform strategic management decisions like evaluating new markets, expanding a product portfolio or sizing potential global market opportunities• Introduced a new market segmentation strategy to align with current market conditions for a $1B+ portfolio; rolled out segmentation to 40+ division heads and senior directors • Valued an early stage medical device company using discounted cash flow (DCF) and precedent transaction analysis for a due diligence resulting in a $100M investment• Created a competitive landscape and sized the current and future market for clinical decision support tools for disease and care management applications in healthcare IT for a leading diagnostics company

• Developed research plans, managed primary and secondary research campaigns and sized market opportunities while overseeing project team members across client engagements covering the genomics research tools market, the clinical stem cell reagents market and the diagnostics testing market across 7 central nervous system indications• Generated client materials including primary research interview guides, survey instruments, market models, and client presentations summarizing key project insights and recommendations• Authored a market report covering the worldwide in-vitro diagnostics (IVD) market including creating a market forecast, identifying market drivers and trends, segmenting the market by company, geography, technology and therapeutic area

• Evaluated secondary resources and conducted a primary market research campaign of 60+ key opinion leaders to assess the global market opportunity for clinical next generation sequencing in oncology for a top diagnostics company• Identified, scheduled and interviewed >150 key healthcare stakeholders including lab directors, clinicians, regulatory advisors and payors across several client engagements covering adjacent opportunities for biospecimens and the clinical NGS oncology testing market• Captured and analyzed primary stakeholder feedback and secondary research to identify market trends, create competitive landscapes and summarize key project findings to help clients make strategic marketing decisions

• Wrote and compiled a monthly newsletter on KGI events that was sent to hundreds of prospective students using a customer relationship management (CRM) program• Identified contact information on potential administrative leads for the Admissions counselors• Contacted a weekly list of prospective students to provide information on KGI and the application process

• Developed a business case to decide whether to retire or update a launched product by assessing the required investment, customer impact, development time, strategic fit of several options, and internal resource requirements across a cross-functional team • Researched the competitive and regulatory landscape, evaluated customer interest, and assessed the threat level of next generation sequencing• Created a tool to evaluate the strategic fit of new companion diagnostic (CDx) projects by evaluating the project sponsor, NPV, market size, indication and other factors for the Genomics and Oncology lifecycle group

Research Advisor: Dr. Jennifer Armstrong• Developed a genetic screen assay to identify effects of chromatin remodeler, Chd1, in D. melanogaster• Presented results to department faculty in the W.M. Keck Science Center Summer Research Symposium• Trained undergraduate students in wing mounting protocol and digitized and organized laboratory files

Research Advisor: Dr. Zhaozhua Tang• Collected data to supplement a genomic library for cancer drug research in conjunction with City of Hope • Conducted a growth curve measuring the I50 point of the cancer drug BPG in Schizosaccharomyces pombe

• Researched and maintained an electronic and physical database of over 100 internships• Organized and catalogued student profiles to maintain an updated contact list• Maintained the overall aesthetics of the office by sorting magazines and updating notices

Laboratory of Dr. Constance Griffin• Karyotyped human chromosomes in a chronic lymphocytic leukemia clinical trial• Observed chromosomal aberrations via karyotyping and fluorescent in situ hybridization (FISH) microscopy